A major acquisition move by an Ahmedabad-based pharmaceutical company, valued at approximately $11.75 billion, is set to reshape India’s position…
Greater Noida’s Government Institute of Medical Sciences (GIMS) has secured formal Department of Biotechnology (DBT) approval for its Institutional Biosafety…